Lawrence Hayward

Affiliations: 
Neurology Univ Mass Worcester, Worcester, MA, United States 
Area:
ALS
Google:
"Lawrence Hayward"
Mean distance: 15.86 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gal J, Kuang L, Barnett KR, et al. (2016) ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathologica
Tibshirani M, Tradewell ML, Mattina KR, et al. (2015) Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Human Molecular Genetics. 24: 773-86
Creedon H, Byron A, Main J, et al. (2014) Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer. Biochemical Society Transactions. 42: 822-30
Fumoleau P, Koch KM, Brain E, et al. (2014) A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study). Breast (Edinburgh, Scotland). 23: 663-9
Lucas B, Ammar T, Khogali S, et al. (2014) Contractile abnormalities of mouse muscles expressing hyperkalemic periodic paralysis mutant NaV1.4 channels do not correlate with Na+ influx or channel content. Physiological Genomics. 46: 385-97
Johnston SR, Kilburn LS, Ellis P, et al. (2013) Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. The Lancet. Oncology. 14: 989-98
Morfini GA, Bosco DA, Brown H, et al. (2013) Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. Plos One. 8: e65235
Convertini P, Zhang J, de la Grange P, et al. (2013) Genome wide array analysis indicates that an amyotrophic lateral sclerosis mutation of FUS causes an early increase of CAMK2N2 in vitro. Biochimica Et Biophysica Acta. 1832: 1129-35
Renaud JM, Hayward LJ. (2012) Lessons learned from muscle fatigue: implications for treatment of patients with hyperkalemic periodic paralysis. Recent Patents On Biotechnology. 6: 184-91
Leahy M, Garcia Del Muro X, Reichardt P, et al. (2012) Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2763-70
See more...